BBVA USA Bancshares’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-31
Closed 514
2019
Q4
$0 Buy
+31
New +$350 ﹤0.01% 666
2018
Q4
Sell
-13,961
Closed -$122K 516
2018
Q3
$122K Sell
13,961
-12,306
-47% -$126K 0.01% 537
2018
Q2
$296K Buy
26,267
+2,224
+9% +$26.5K 0.02% 453
2018
Q1
$267K Buy
24,043
+1,831
+8% +$22.9K 0.02% 471
2017
Q4
$284K Buy
22,212
+3,213
+17% +$42.4K 0.02% 462
2017
Q3
$270K Buy
18,999
+1,657
+10% +$20.8K 0.02% 467
2017
Q2
$224K Sell
17,342
-3,861
-18% -$49.7K 0.01% 501
2017
Q1
$304K Buy
21,203
+82
+0.4% +$1.21K 0.02% 452
2016
Q4
$330K Buy
21,121
+8,233
+64% +$113K 0.02% 441
2016
Q3
$152K Buy
+12,888
New +$170K 0.01% 540

Other funds holding CCRN

BBVA USA Bancshares's CCRN Position: Q1 2020 in Review

BBVA USA Bancshares sold out of Cross Country Healthcare (CCRN) in Q1 2020, closing a stake of 31 shares.

BBVA USA Bancshares first reported a position in CCRN in Q3 2016 and held it in 10 quarters. The position peaked at $330K in Q4 2016. 140 funds tracked by Wall St. Rank hold CCRN as of Q1 2020.

  • BBVA USA Bancshares reported no remaining Cross Country Healthcare position as of Q1 2020 after selling out during the quarter.
  • BBVA USA Bancshares sold 31 Cross Country Healthcare shares in Q1 2020.
  • BBVA USA Bancshares first reported a position in Cross Country Healthcare in Q3 2016 and held it in 10 quarters.
  • BBVA USA Bancshares's Cross Country Healthcare position peaked at $330K in Q4 2016.
  • 140 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2020.

Based on BBVA USA Bancshares's 13F filing for Q1 2020, filed 27 Apr 2020.